Please login to the form below

Not currently logged in
Email:
Password:

Teva appoints Timothy Wright as business development head

The former Covidien Pharma president mostrecently led a US cancer centre

Teva has appointed Timothy Wright as its new head of business development, strategy and innovation.

He joins the Israeli pharma company from The Ohio State University Comprehensive Cancer Center, where he served as director of its Drug Discovery and Development Institute.

Prior to that Wright spent more than 25 years in pharma and biotech, most recently as president of Covidien Pharma from 2007-10.

Before that he was CEO (Interim) and Presidentat AAI Pharmaceuticals/Xanodyne and held various roles at Elan Pharmaceuticals and DuPont Merck Pharmaceutical Company.

In his new, newly-created role Wright, whose appointment will be effective from April 13, will be responsible for identifying new sources of innovation and growth that are extensions of Teva's current business model.

Erez Vigodman, Teva's president and CEO, said: “The addition of Tim to our leadership team complements the strong management capabilities we have in Teva. He has a wealth of global experience which will serve us well as we look to create a new and exciting future for Teva.

“Tim is known for leading the transformation of large companies. His significant experience across various aspects of healthcare and unique perspective will enable us to realise our full potential at this critical time of change in the pharmaceutical industry.”

26th March 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics